AB0529 Long-Term Glucocorticoid Monotherapy Can Lead To Remission in Japanese Patients with Polymyalgia Rheumatica without Notable Adverse Effects

Background

Polymyalgia rheumatica (PMR) is a common inflammatory condition of elderly persons. Clinical symptoms are improved by low-dose glucocorticoids (GCs). However, most patients require long-term GC therapy, because relapses are common. The recent recommendations for the management of PMR¹⁾ suggested early introduction of methotrexate (MTX) in addition to GCs in patients with a relapse, and/or without a significant...